rs199422194
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_018136.5(ASPM):c.9697C>T(p.Arg3233*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000822 in 1,460,386 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. R3233R) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_018136.5 stop_gained
Scores
Clinical Significance
Conservation
Publications
- microcephaly 5, primary, autosomal recessiveInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
- autosomal recessive primary microcephalyInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| ASPM | ENST00000367409.9 | c.9697C>T | p.Arg3233* | stop_gained | Exon 24 of 28 | 1 | NM_018136.5 | ENSP00000356379.4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000799 AC: 2AN: 250264 AF XY: 0.00000739 show subpopulations
GnomAD4 exome AF: 0.00000822 AC: 12AN: 1460386Hom.: 0 Cov.: 32 AF XY: 0.00000688 AC XY: 5AN XY: 726536 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Microcephaly 5, primary, autosomal recessive Pathogenic:4Other:1
- -
- -
- -
PVS1 PM2 -
The homozygous c.9697C>T variant is located in the coding exon 24 of the ASPM gene, resulting in a premature termination codon (p.Arg3233*). This variant is predicted to cause loss of function by nonsense-mediated decay (NMD), because the premature termination codon (PTC) is not occurring in the 3′ most exon or the 3′-most 50 bp of the penultimate exon of the canonical transcript (NM_018136.5). This variant is rare in population database (GnomAD V4: 0,0007%), where it appears only in the heterozygous state. ClinVar contains an entry for this variant (Variation ID: 21634). It has also been identified in compound heterozygous state with a pathogenic variant in two siblings with MCPH (MCPH5) (Moriwaki et al., 2019). Based on these findings, this variant was classified as pathogenic according to ACMG/Clingen (PVS1, PM2_Supporting, PM3). -
not provided Pathogenic:2
This sequence change creates a premature translational stop signal (p.Arg3233*) in the ASPM gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in ASPM are known to be pathogenic (PMID: 19028728, 23611254). This variant is present in population databases (rs199422194, gnomAD 0.003%). This premature translational stop signal has been observed in individual(s) with primary microcephaly (PMID: 19353628, 31934343). ClinVar contains an entry for this variant (Variation ID: 21634). For these reasons, this variant has been classified as Pathogenic. -
The R3233X nonsense variant has been reported previously as a homozygous variant in multiple families with MCPH (Muhammad et al., 2009; Abdel-Hamid et al., 2016). The R3233X variant is not observed at a significant frequency in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). This pathogenic variant is predicted to cause loss of normal protein function either through protein truncation or nonsense-mediated mRNA decay. -
See cases Pathogenic:1
ACMG classification criteria: PVS1, PM2 -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at